San Francisco, CA, January 08, 2015 --(PR.com
)-- Positive outlook on global pharmaceutical industry is expected to remain a key driving factor for global specialty enzymes market. New developments in biotechnology coupled with growing awareness of green chemistry and enzyme engineering are also expected to drive the global market over the next six years. Specific properties in specialty enzyme give it a competitive advantage over conventional enzymes which is expected to have a positive influence on the market growth. Specialty enzymes are incorporated in pharmaceutical drugs to increase their performance which are further used for treating fatal diseases such as cancer, asthma and cardiovascular diseases. They specialty enzymes based drugs are also used for treating hay fever, lysosomal storage diseases and severe joint pain caused by age. Increasing prevalence of cancer and cardiovascular diseases on account of changing lifestyle of consumers is expected to drive their demand in pharmaceutical industry.
Maintenance of pH and operational temperature of the enzymes is expected to remain a key concern for market participants. Ethical & legal issues and lack of awareness regarding its benefits particularly in developing countries is also expected to pose challenge for market participants. Growth of pharmaceutical industry particularly in BRIC nations is expected to have a positive influence on the overall specialty enzyme market over the forecast period. Carbohydrases and proteases are the most frequently used specialty enzymes.
View Specialty Enzymes Market Report with TOC @ http://www.grandviewresearch.com/industry-analysis/specialty-enzymes-market
North America was the largest regional market on account of technology advancements and sophisticated healthcare infrastructure in the U.S. Asia Pacific is expected to witness significant growth over next six years mainly on account of increase in demand for high quality products and rapid growth of major end-use industries particularly in China and India.
Some leading players operating in the global specialty enzymes market include Advanced Enzyme Technology Ltd., Codexis Inc., Amano Enzyme Inc., Nagase & Co. Ltd., BASF, Roche Holding AG and Sanofi S.A.
Grand View Research provides strategic objective insights. For more information, visit http://www.grandviewresearch.com